$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000111748022000020 Filed on May 16, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$15.00K	$1.435M
YoY Change	-98.95%	15.63%
Cost Of Revenue	$114.0K	$0.00
YoY Change
Gross Profit	-$99.00K	$1.435M
YoY Change	-106.9%
Gross Profit Margin	-660.0%	100.0%
Selling, General & Admin	$5.632M	$4.140M
YoY Change	36.04%	28.97%
% of Gross Profit		288.5%
Research & Development	$19.04M	$11.86M
YoY Change	60.51%	32.55%
% of Gross Profit		826.62%
Depreciation & Amortization	$24.00K	$71.00K
YoY Change	-66.2%	-36.61%
% of Gross Profit		4.95%
Operating Expenses	$24.67M	$98.89M
YoY Change	-75.05%	713.63%
Operating Profit	-$24.77M	-$97.45M
YoY Change	-74.58%	793.0%
Interest Expense	$4.000K	$40.00K
YoY Change	-90.0%	-91.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$24.77M	-$97.42M
YoY Change	-74.58%	834.93%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$24.77M	-$97.42M
YoY Change	-74.58%	834.88%
Net Earnings / Revenue	-165113.33%	-6788.5%
Basic Earnings Per Share	-$0.28	-$1.21
Diluted Earnings Per Share	-$0.28	-$1.21
COMMON SHARES
Basic Shares Outstanding	87.09M shares	80.20M shares
Diluted Shares Outstanding	87.09M shares	80.20M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$53.38M	$145.0M
YoY Change	-63.18%	40.76%
Cash & Equivalents	$31.96M	$32.08M
Short-Term Investments	$21.42M	$112.9M
Other Short-Term Assets	$5.766M	$2.700M
YoY Change	113.56%	3.85%
Inventory	$3.400M
Prepaid Expenses
Receivables		$482.0K
Other Receivables		$0.00
Total Short-Term Assets	$62.55M	$148.1M
YoY Change	-57.78%	38.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$229.0K	$218.0K
YoY Change	5.05%	-49.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$7.500M
YoY Change	-100.0%
Other Assets	$439.0K	$29.00K
YoY Change	1413.79%	81.25%
Total Long-Term Assets	$2.966M	$10.51M
YoY Change	-71.78%	921.57%
TOTAL ASSETS
Total Short-Term Assets	$62.55M	$148.1M
Total Long-Term Assets	$2.966M	$10.51M
Total Assets	$65.52M	$158.6M
YoY Change	-58.7%	47.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.494M	$2.181M
YoY Change	60.2%	94.04%
Accrued Expenses	$11.72M	$6.067M
YoY Change	93.14%	9.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$14.00M
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.21M	$22.25M
YoY Change	-31.63%	233.05%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.506M	$2.800M
YoY Change	-10.5%
Total Long-Term Liabilities	$2.506M	$2.800M
YoY Change	-10.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.21M	$22.25M
Total Long-Term Liabilities	$2.506M	$2.800M
Total Liabilities	$17.72M	$25.00M
YoY Change	-29.13%	271.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$910.4M	-$809.8M
YoY Change	12.42%	19.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$47.80M	$133.6M
YoY Change
Total Liabilities & Shareholders Equity	$65.52M	$158.6M
YoY Change	-58.7%	47.21%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$24.77M	-$97.42M
YoY Change	-74.58%	834.88%
Depreciation, Depletion And Amortization	$24.00K	$71.00K
YoY Change	-66.2%	-36.61%
Cash From Operating Activities	-$23.45M	-$37.90M
YoY Change	-38.13%	250.24%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$75.00K
YoY Change	-100.0%	971.43%
Acquisitions
YoY Change
Other Investing Activities	$53.47M	-$88.64M
YoY Change	-160.32%	-585.7%
Cash From Investing Activities	$53.47M	-$88.72M
YoY Change	-160.27%	-586.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$107.8M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$13.46M	$111.7M
YoY Change	-112.05%	48678.6%
NET CHANGE
Cash From Operating Activities	-$23.45M	-$37.90M
Cash From Investing Activities	$53.47M	-$88.72M
Cash From Financing Activities	-$13.46M	$111.7M
Net Change In Cash	$16.56M	-$14.91M
YoY Change	-211.07%	-294.84%
FREE CASH FLOW
Cash From Operating Activities	-$23.45M	-$37.90M
Capital Expenditures	$0.00	$75.00K
Free Cash Flow	-$23.45M	-$37.97M
YoY Change	-38.25%	250.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0789
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-35867
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0903395
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2505 Meridian Parkway
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Durham
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27713
CY2022Q1	dei	City Area Code CityAreaCode	919
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	806-1074
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	CMRX
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	87436180	shares
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31957000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15397000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21421000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	72970000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	3406000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	2760000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5766000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4678000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	62550000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	95805000	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	2022000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	229000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	253000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2298000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2404000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	439000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	56000	USD
CY2022Q1	us-gaap	Assets Assets	65516000	USD
CY2021Q4	us-gaap	Assets Assets	100540000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3494000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2788000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11718000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13108000	USD
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	14000000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15212000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29896000	USD
CY2022Q1	cmrx	Loan Fees Liability Non Current LoanFeesLiabilityNonCurrent	250000	USD
CY2021Q4	cmrx	Loan Fees Liability Non Current LoanFeesLiabilityNonCurrent	0	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2256000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2392000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	17718000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	32288000	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2021Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87436180	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87436180	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	86884266	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	86884266	shares
CY2022Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	87000	USD
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	87000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	958147000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	953782000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-73000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-910363000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-885596000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	47798000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	68252000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	65516000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	100540000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1435000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	114000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	-99000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1435000	USD
CY2022Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	19040000	USD
CY2021Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	11862000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5632000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4136000	USD
CY2022Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2021Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	82890000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	24672000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	98888000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-24771000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-97453000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	38000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24767000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-97415000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-52000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-43000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24819000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-97458000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87088804	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87088804	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80204094	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80204094	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	68252000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3708000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	102000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	555000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-52000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24767000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24819000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	47798000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	73376000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2584000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3530000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	330000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	43445000	USD
CY2021Q1	cmrx	Equity Issuance Cost EquityIssuanceCost	7200000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	107842000	USD
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	134000	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	169000	shares
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-43000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-97415000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-97458000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	133649000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-24767000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-97415000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	24000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	71000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	33000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-53000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-128000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3708000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2584000	USD
CY2022Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2021Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	43445000	USD
CY2022Q1	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	0	USD
CY2021Q1	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	14000000	USD
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	1000	USD
CY2021Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2000	USD
CY2022Q1	cmrx	Operating Lease Right Of Use Asset Amortization Expense And Straight Line Rent OperatingLeaseRightOfUseAssetAmortizationExpenseAndStraightLineRent	63000	USD
CY2021Q1	cmrx	Operating Lease Right Of Use Asset Amortization Expense And Straight Line Rent OperatingLeaseRightOfUseAssetAmortizationExpenseAndStraightLineRent	41000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	159000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	646000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1002000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	309000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-912000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-280000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23447000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37896000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	3400000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75000	USD
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	5258000	USD
CY2021Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	91944000	USD
CY2022Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2021Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	7554000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	7699000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2007000	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	51026000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	8850000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	53467000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-88716000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	102000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3530000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	556000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	330000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	107843000	USD
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	118000	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2022Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-14000000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13460000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	111703000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16560000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14909000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15397000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46989000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31957000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32080000	USD
CY2021Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	4642000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2600000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	800000	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	100000	USD
CY2022Q1	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	6155000	USD
CY2022Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	3068000	USD
CY2021Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	5491000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2495000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2975000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11718000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13108000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. In addition to estimates discussed in other sections of this Quarterly Report on Form 10-Q, the most significant estimates in the Company’s consolidated financial statements relate to the valuation of stock options and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div>
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	21494000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	73000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21421000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	75013000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	25000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	74992000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	21421000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	73000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	21421000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	73000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	10	security
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	security
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	10	security
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	100000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	46892000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	25000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	46892000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	25000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	18	security
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	security
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	18	security
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	21421000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	21421000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y4M2D
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	200000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2298000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	524000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2256000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2780000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	539000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	736000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	759000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	781000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	467000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3282000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	502000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2780000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	637000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	736000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	759000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	781000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	467000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3380000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	556000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2824000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	98000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	133000	USD
CY2022Q1	cmrx	Lessee Operating Sublease Area Of Sublease Property LesseeOperatingSubleaseAreaOfSubleaseProperty	3537	sqft
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	12000	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3708000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2584000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD

Files In Submission

Name	View Source	Status
0001117480-22-000020-index-headers.html	Edgar Link	pending
0001117480-22-000020-index.html	Edgar Link	pending
0001117480-22-000020.txt	Edgar Link	pending
0001117480-22-000020-xbrl.zip	Edgar Link	pending
a20220331cmrxex-311.htm	Edgar Link	pending
a20220331cmrxex-312.htm	Edgar Link	pending
a20220331cmrxex-321.htm	Edgar Link	pending
a20220331cmrxex-322.htm	Edgar Link	pending
cmrx-20220331.htm	Edgar Link	pending
cmrx-20220331.xsd	Edgar Link	pending
cmrx-20220331_cal.xml	Edgar Link	unprocessable
cmrx-20220331_def.xml	Edgar Link	unprocessable
cmrx-20220331_htm.xml	Edgar Link	completed
cmrx-20220331_lab.xml	Edgar Link	unprocessable
cmrx-20220331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2022 Q1 Form 10-Q Financial Statement

#000111748022000020 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2022 Q1 Form 10-Q Financial Statement

#000111748022000020 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx